What is the University of Texas (UT) classification system for diabetic foot ulcers and how is it used in diagnosis and treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

University of Texas Classification of Diabetic Foot Ulcers

The University of Texas (UT) classification system uses a 4×4 matrix combining wound depth grades (0-3) with stages (A-D) based on infection and ischemia status to systematically categorize diabetic foot ulcers and predict complication risk. 1

Structure of the UT Classification System

Depth Grades (0-3)

  • Grade 0: Pre- or post-ulcerative lesion that is completely epithelialized 2
  • Grade 1: Superficial wound not involving tendon, capsule, or bone 2
  • Grade 2: Wound penetrating to tendon or joint capsule 2
  • Grade 3: Wound penetrating to bone or deep abscess 1

Stages (A-D) Based on Infection/Ischemia

  • Stage A: No infection or ischemia present 2
  • Stage B: Infection present, no ischemia 1
  • Stage C: Ischemia present, no infection 1
  • Stage D: Both infection and ischemia present 1

Clinical Application and Assessment

The UT system requires vascular assessment using clinical signs plus non-invasive testing (transcutaneous oxygen measurements, ankle-brachial index, or toe systolic pressure) to determine ischemia status. 1 This requirement for equipment and clinical expertise reduces feasibility in resource-limited settings compared to simpler classification systems. 1

Prognostic Value

The UT classification successfully predicts complication likelihood, with higher grades and stages correlating with significantly higher amputation rates in wounds deeper than superficial ulcers. 1, 3 Patients with more severe classifications (higher grade/stage combinations) demonstrate worse clinical outcomes. 1

Limitations and Current Recommendations

Key Deficiencies

  • Does not include ulcer size/area, which independently predicts outcomes 1
  • Does not assess loss of protective sensation (neuropathy), critical for offloading recommendations 1
  • Requires vascular testing equipment not universally available 1
  • Evidence quality is low with most studies at high risk of bias 1

Important Guideline Caveat

The International Working Group on the Diabetic Foot (2024) strongly recommends AGAINST using the UT system—or any classification system—to predict individual patient outcomes due to weak evidence quality and poor applicability. 1, 3 The positive likelihood ratios are below 5 and negative likelihood ratios around 0.2-0.4, indicating only small changes in pre-to-post test probability of clinical outcomes. 1

Recommended Alternative Approach

For routine clinical communication and documentation, use the SINBAD system instead, which includes site, ischemia, neuropathy, bacterial infection, area, and depth. 3, 2 The SINBAD system has been validated in 12 studies with substantial-to-good reliability. 3

When infection is present or suspected, apply the IDSA/IWGDF infection classification system (grades 1-4) to guide antibiotic selection and hospitalization decisions. 3, 2 This system specifically addresses infection severity from uninfected (grade 1) through mild, moderate, to severe with systemic inflammatory response (grade 4). 1

The UT classification may still be used for research purposes and general communication about wound characteristics, but clinicians should recognize its limitations for individual prognostication and consider supplementing with other assessment tools that capture neuropathy and wound area. 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Classification Systems for Diabetic Foot

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Classification and Management of Diabetic Foot Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diabetic foot ulcers: pathogenesis and management.

American family physician, 2002

Related Questions

What is the recommended system for grading diabetic foot ulcers?
What is the classification of diabetic foot according to PEDIS (Perfusion, Extent, Depth, Infection, Sensation) in a patient with a history of diabetes mellitus?
What are the current guidelines for diabetic foot ulcer management according to the Infectious Diseases Society of America (IDSA)?
How is the San Elian classification system interpreted in diabetic foot?
What is the classification and treatment of diabetic foot?
What are the signs and symptoms of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome in pregnant women?
What is the best course of action for an elderly patient with expiratory wheezing, using Ventolin (albuterol), and a month-long cough, without a smoking history?
Is Tirzepatide (glucagon-like peptide-1 (GLP-1) receptor agonist) only a GLP-1 receptor agonist in patients with type 2 diabetes?
What are the key components of a Medicare annual wellness visit for an elderly patient with potential chronic conditions?
What is the best course of management for a young to middle-aged adult patient with a history of Attention Deficit Hyperactivity Disorder (ADHD), Generalized Anxiety Disorder (GAD), and substance dependence, currently taking Prozac (fluoxetine) 20mg, diazepam (Valium) 10mg twice daily, and various supplements, after being hospitalized for nitrous oxide abuse and subsequent development of leg tingling and impaired mobility?
Is it safe to crush medications and administer them together in patients with swallowing difficulties, such as geriatric individuals or those with neurological disorders?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.